News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
45,533 Results
Type
Article (3589)
Company Profile (27)
Press Release (41917)
Section
Business (14394)
Career Advice (57)
Deals (1836)
Drug Delivery (7)
Drug Development (3813)
Employer Resources (3)
FDA (594)
Job Trends (1297)
News (20300)
Policy (1410)
Tag
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (428)
Allergies (3)
Alliances (5648)
ALS (8)
Alzheimer's disease (58)
Antibody-drug conjugate (ADC) (2)
Approvals (596)
Artificial intelligence (34)
Autoimmune disease (2)
Automation (7)
Bankruptcy (15)
Best Places to Work (1151)
BIOSECURE Act (12)
Biosimilars (1)
Biotechnology (25)
Bladder cancer (7)
Brain cancer (3)
Breast cancer (47)
Cancer (268)
Cardiovascular disease (9)
Career advice (57)
Career pathing (1)
CAR-T (8)
Cell therapy (44)
Cervical cancer (1)
Clinical research (2674)
Collaboration (117)
Compensation (20)
Complete response letters (1)
COVID-19 (204)
CRISPR (17)
C-suite (14)
Cystic fibrosis (7)
Data (177)
Diabetes (13)
Diagnostics (1401)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (11)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (5)
Earnings (3485)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (6468)
Executive appointments (66)
FDA (650)
Featured Employer (6)
Funding (47)
Gene editing (48)
Generative AI (3)
Gene therapy (47)
GLP-1 (33)
Government (298)
Guidances (6)
Healthcare (1234)
Huntington's disease (2)
Immunology and inflammation (2)
Infectious disease (216)
Inflammatory bowel disease (10)
Influenza (5)
Intellectual property (8)
Interviews (5)
IPO (799)
Job creations (182)
Job search strategy (53)
Layoffs (17)
Legal (224)
Liver cancer (8)
Lung cancer (45)
Lymphoma (11)
Machine learning (1)
Management (1)
Manufacturing (26)
MASH (1)
Medical device (357)
Medtech (358)
Mergers & acquisitions (1072)
Metabolic disorders (21)
NASH (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (1)
Neuroscience (88)
NextGen: Class of 2025 (393)
Non-profit (302)
Northern California (251)
Now hiring (2)
Obesity (5)
Opinion (27)
Ovarian cancer (1)
Pain (4)
Pancreatic cancer (11)
Parkinson's disease (9)
Partnered (1)
Patents (10)
Patient recruitment (3)
Peanut (1)
People (4561)
Pharmaceutical (2)
Phase I (1188)
Phase II (1273)
Phase III (815)
Pipeline (64)
Policy (15)
Postmarket research (42)
Preclinical (644)
Press Release (22)
Prostate cancer (9)
Radiopharmaceuticals (3)
Rare diseases (37)
Real estate (360)
Regulatory (1010)
Reports (3)
Research institute (513)
Resumes & cover letters (2)
RNA editing (1)
RSV (1)
Schizophrenia (1)
Series A (11)
Series B (5)
Sickle cell disease (14)
Southern California (227)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (365)
Supply chain (5)
United States (1730)
Vaccines (22)
Venture capitalists (2)
Weight loss (4)
Date
Last 7 days (29)
Last 30 days (145)
Last 365 days (2556)
2025 (641)
2024 (2791)
2023 (3295)
2022 (4481)
2021 (4641)
2020 (3962)
2019 (3043)
2018 (2272)
2017 (2570)
2016 (2492)
2015 (2550)
2014 (1649)
2013 (1389)
2012 (1429)
2011 (1420)
2010 (1254)
Location
Africa (58)
Alabama (8)
Alaska (1)
Arizona (22)
Asia (2378)
Australia (360)
California (591)
Canada (80)
China (42)
Colorado (11)
Connecticut (30)
Delaware (4)
Europe (5743)
Florida (59)
Georgia (4)
Idaho (1)
Illinois (20)
India (3)
Indiana (9)
Iowa (3)
Japan (17)
Kansas (2)
Kentucky (1)
Louisiana (1)
Maine (3)
Maryland (61)
Massachusetts (352)
Michigan (15)
Minnesota (18)
Missouri (7)
Montana (2)
Nebraska (5)
Nevada (5)
New Hampshire (3)
New Jersey (90)
New Mexico (11)
New York (75)
North Carolina (124)
North Dakota (6)
Northern California (251)
Ohio (18)
Oregon (1)
Pennsylvania (49)
Rhode Island (3)
South America (61)
South Carolina (2)
Southern California (227)
Tennessee (3)
Texas (92)
Utah (22)
Virginia (5)
Washington D.C. (4)
Washington State (35)
Wisconsin (9)
45,533 Results for "eagle genomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
April 1, 2025
·
8 min read
Press Releases
Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration
November 18, 2024
·
7 min read
Press Releases
Moss Genomics Announces Genomics Business Update, Integrating Blockchain for Genomic Security and Transparency
February 25, 2025
·
7 min read
Press Releases
Ecotone Achieves Breakthrough in Human Genome Understanding with Novel AI Technology
AI-Powered Genomic Mapping Could Revolutionize Treatment of Rare Genetic Diseases
January 16, 2025
·
1 min read
Business
Eagle Pharmaceuticals Announces Management Change
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced a change in management.
November 29, 2023
·
5 min read
Press Releases
Revvity Expands Alliance with Genomics England to Drive Research into Newborn Genomic Sequencing in England
March 21, 2025
·
3 min read
Pharm Country
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided an update on its bendamustine intellectual property portfolio.
January 18, 2024
·
7 min read
Press Releases
CD Genomics Launches Innovative NGS-BSP to Enhance Genomic Understanding
March 27, 2025
·
1 min read
Press Releases
Moss Genomics Announces Listing on the OTC Markets
April 11, 2025
·
6 min read
Policy
Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
Eagle Pharmaceuticals, Inc. announced that it received a notice on May 20, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC advising the Company that it has initiated a process to delist the Company’s securities from Nasdaq because the Company had not filed its Form 10-Q for the quarter ended September 30, 2023 and its Form 10-K for the year ended December 31, 2023 by May 13, 2024.
May 22, 2024
·
7 min read
1 of 4,554
Next
